Skip to main content
Log in

Hepatic extraction of morphine is impaired in cirrhosis

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Using hepatic vein catheterization this study has provided the first direct measurement of morphine hepatic extraction in 8 controls and 8 cirrhotics.

The extraction ratio was 0.52 in the control group and was reduced by 25% in the cirrhotics. This reduction is due to impaired enzyme capacity rather than reduced blood flow. The effect of cirrhosis is less than that reported in similar studies of high clearance oxidized drugs and this lends support to the concept that glucuronidation may be relatively spared in cirrhosis.

A discrepancy between the systemic clearance and the hepatic clearance provides indirect support for extra-hepatic metabolism of morphine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rowland M, Benet LZ, Graham GG (1973) Clearance concepts in pharmacokinetics. J Pharmacokinet Biopharm 1: 123–136

    Google Scholar 

  2. Wilkinson GR, Shand DG (1975) A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18: 377–389

    Google Scholar 

  3. Klotz U, Avant GR, Hoyumpa A, Schenker S, Wilkinson GR (1975) The effect of age and liver disease on the disposition of diazepam in adult man. J Clin Invest 55: 347–359

    Google Scholar 

  4. Roberts RK, Wilkinson GR, Branch RA, Schenker S (1978) The effects of age and liver disease on the disposition of chlordiazepoxide. Gastroenterology 75: 479–486

    Google Scholar 

  5. Pessayre D, Lebrec D, Descatoire D, Peignoux M, Benhamou J-P (1978) Mechanism for reduced drug clearance in patients with cirrhosis. Gastroenterology 74: 566–571

    Google Scholar 

  6. Huet P-M, Villeneuve J-P (1983) Determinants of drug disposition in patients with cirrhosis. Hepatology 3: 913–918

    Google Scholar 

  7. Neal EA, Meffin PJ, Gregory PB, Blaschke TF (1979) Enhanced bioavailability and decreased clearance of analgaesics in patients with cirrhosis. Gastroenterology 77: 96–102

    Google Scholar 

  8. Shull HJ, Wilkinson GR, Johnson R, Schenker S (1976) Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann Intern Med 84: 420–425

    Google Scholar 

  9. Kraus JW, Desmond PV, Marshall JP, Johnson RF, Schenker S, Wilkinson GR (1978) Effect of age and liver disease on disposition of lorazepam. Clin Pharmacol Ther 24: 411–419

    Google Scholar 

  10. Ghabrial H, Desmond PV, Watson KJR, Gijsbers AJ, Harman PJ, Breen KJ, Mashford ML (1986) The effects of age and chronic liver disease on the elimination of temazepam. Eur J Clin Pharmacol 30: 93–97

    Google Scholar 

  11. Stanski DR, Greenblatt DJ, Lowenstein E (1978) Kinetics of intravenous and intramuscular morphine. Clin Pharmacol Ther 24: 52–59

    Google Scholar 

  12. Watson KJR, Ghabrial H, Harman PJ, Breen KJ, Mashford ML, Desmond PV (1986) Morphine disposition in cirrhosis. Gastroenterology 88: 1704

    Google Scholar 

  13. Patwardhan RV, Johnson RF, Hoyumpa A, Sheehan JJ, Desmond PV, Wilkinson GR, Branch RA, Schenker S (1981) Normal metabolism of morphine in cirrhosis. Gastroenterology 81: 1006–1011

    Google Scholar 

  14. Caesar J, Shaldon S, Chiandussi L, Guevera L, Sherlock S (1961) The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 21: 43–57

    Google Scholar 

  15. Rappaport PL, Thiess JJ (1982) High-pressure liquid chromatographic analysis of indocyanine green. J Pharm Sci 71: 157–161

    Google Scholar 

  16. Crotty B, Mashford ML, Desmond PV (1988) There is no metabolism of morphine in the arm or the lung in man. Clin Exp Pharmacol Physiol 12 [Supplement]: 144

    Google Scholar 

  17. Metzler CM, Elfring GL, McEwen AJ (1974) A user's manual for NONLIN and associated programs. The Upjohn Co, Kalamazoo, Mich

    Google Scholar 

  18. Ryan TA, Joiner BL, Ryan BF (1981) Minitab Reference Manual. Minitab Inc, University Park, Pa

    Google Scholar 

  19. Huet P-M, Villeneuve J-P, Pomier-Layrargues G, Marleau D (1985) Hepatic circulation in cirrhosis. Clin Gastroenterol 14: 155–168

    Google Scholar 

  20. Dutton GJ (1980) Glucuronidation of drugs and other compounds. CRC Press, Boca Raton

    Google Scholar 

  21. Zakim D (1986) The role of membrane lipids in the regulation of membrane-bound enzymes. Prog Liver Dis 8: 65–80

    Google Scholar 

  22. Desmond PV, James R, Schenker S, Gerkens JF, Branch RA (1981) Preservation of glucuronidation in carbon tetrachloride induced acute liver injury in rats. Biochem Pharmacol 30: 993–999

    Google Scholar 

  23. Otani G, Abou-El-Makhram MM, Bock KW (1976) UDP-glucuronyltransferase in perfused rat liver and in microsomes-III. Effects of galactosamine and carbon tetrachloride on the glucuronidation of 1-naphthol and bilirubin. Biochem Pharmacol 25: 1293–1297

    Google Scholar 

  24. Boyer TD, Zakim D (1983) The effect of choline deficiency on the activity of a phosphatidylcholine-requiring enzyme: activity and properties of UDP-glucuronyltransferase in choline-deficient rats. Biochem Biophys Res Commun 114: 418–424

    Google Scholar 

  25. Aitio A (1974) Effect of chrysene and carbon tetrachloride administration on rat hepatic microsomal monooxygenase and UDP glucuronosyltransferase activity. FEBS Lett 42: 46–49

    Google Scholar 

  26. Schali C, Roch-Ramel F (1982) Transport and metabolism of (3H)morphine in isolated nonperfused proximal tubular segments of the rabbit kidney. J Pharmacol Exp Ther 223: 811–815

    Google Scholar 

  27. Josting D; Winne D, Bock KW (1976) Glucuronidation of paracetamol, morphine and 1-naphthol in the rat intestinal loop. Biochem Pharmacol 25: 613–616

    Google Scholar 

  28. Jacqz E, Ward S, Johnson R, Schenker S, Gerkens J, Branch RA (1986) Extrahepatic glucuronidation of morphine in the dog. Drug Metab Dispos 14: 627–630

    Google Scholar 

  29. Dahlstrom BE, Paalzow LK (1978) Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the rat. J Pharmacokinet Biopharm 6: 505–519

    Google Scholar 

  30. Iwamoto K, Klaassen CD (1977) First-pass effect of morphine in rats. J Pharmacol Exp Ther 200: 236–234

    Google Scholar 

  31. Pacifici GM, Bencini C, Rane A (1986) Presystemic glucuronidation of morphine in humans and rhesus monkeys: subcellular distribution of the UDP-glucuronyltransferase in the liver and intestine. Xenobiotica 16: 123–128

    Google Scholar 

  32. Owen JA, Sitar DS (1983) Morphine analysis by high performance liquid chromatography. J Chromatogr 276: 202–207

    Google Scholar 

  33. Murphy MR; Hug CC (1981) Pharmacokinetics of intravenous morphine in patients anaesthetised with enflurane-nitrous oxide. Anesthesiology 54: 187–192

    Google Scholar 

  34. Watson KJR, Ghabrial H, Mashford ML, Harman PJ, Breen KJ, Desmond PV (1986) The oral contraceptive pill increases morphine clearance but does not increase hepatic blood flow. Gastroenterology 90: 1779

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crotty, B., Watson, K.J.R., Desmond, P.V. et al. Hepatic extraction of morphine is impaired in cirrhosis. Eur J Clin Pharmacol 36, 501–506 (1989). https://doi.org/10.1007/BF00558076

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00558076

Key words

Navigation